Glutathione IV Therapy FAQ's Glutathione IV therapy is beneficial for a wide range of individuals, particularly those with low glutathione levels due to factors like chronic stress, exposure to toxins, and aging

Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)

However, it is important to emphasize that while these mechanistic connections are biologically plausible, there is currently no official FDA indication linking GLP-1 medications to Alzheimer's disease prevention or treatment
increases the muscles performance and overall body endurance by reducing muscle fatigue
10.1093/humupd/dmp008 Hum Reprod Update
GRAM contains no artificial colours, no fat and no sugar, and is suitable for vegans